Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
POC Urinalysis Market: Test Type, By Application, By End-User By Geography
POC Urinalysis Market size is valued at US$ 3.44 billion in 2022. It is expected to reach US$ 4.95 billion by 2029, at a CAGR of 6.9% from 2023-2029. Latest technologies and increased demand for point-of-care (POC) urine diagnostic tests are projected to drive the urinalysis research market. In the laboratory, there is a strong demand for technically improved urinalysis tools that can offer reliable results in a fast manner. Integrated systems that can do the initial screening and required confirmation testing with microscopy are being used by several mid-and high-volume laboratories to automate their urine testing. Laboratories have had a constant demand for adaptable urinalysis solutions to meet the rising needs of their network. On the other hand, rising applications from advanced markets, as well as the adoption of integrated urinalysis systems, would create several possibilities, resulting in the rise of the point of care (POC) urinalysis market over the projection period. The accessibility of low-quality devices, as well as erroneous findings during crises, are expected to stifle the development of the point-of-care (POC) urinalysis market over the forecast period. The high costs associated with the use of automated analyzers will be the most significant impediment to the market's expansion. Urinalysis is an important aspect of any normal health examination.
In addition to disease-specific cardiac biomarkers, chemical substances, and cells/casts, this diagnostic approach may identify disease-specific biomarkers, chemical compounds, and cells/casts in urine samples. Urinalysis is also commonly used for early disease detection and pregnancy and fertility testing. The urinalysis market is predicted to expand due to factors such as rising worldwide incidence of kidney illnesses and urinary tract infections, rising health problems connected with the elderly population, and the development of increasingly improved equipment. POC presents a number of issues, the most significant of which is quality assurance. The conclusion of the test is frequently contrasted with traditional pathology to ensure the accuracy of the test result. Several fast diagnostic tests, especially those used in emergency situations, have failed to deliver correct results. The lack of clarity about the outcome is preventing the widespread use of point-of-care diagnostic equipment. For a complete list of the variables that will drive and challenge the growth of the POC Urinalysis market over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
6.9%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Factors such as growing demand for point-of-care testing, enhancement in the global geriatric population, new advancement in technology innovation of urinalysis propels the market growth of POC Urinalysis. Moreover, growth in healthcare expenditure, development of basic medical insurance systems in the near future boost the growth of the POC Urinalysis market. However, factors like lack of laboratory staff, High cost associated with advanced urine analyzers, acceptance of fully automated urine analyzers in growing economies is lower, and stringent regulatory framework may hamper the growth of the POC Urinalysis market. The POC is utilized to distinguish urinary tract diseases (UTI) and different issues of the urinary tract. In patients with intense or constant conditions, for example, kidney ailment, the urinalysis might be requested at interims as a quick technique to help screen organ capacity, status, and reaction to treatment.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2022 |
US$ 3.44 billion |
Market Size in 2029 |
US$ 4.95 billion |
Market CAGR |
6.9% |
By Test Type |
|
By Application |
|
By End User |
|
Download Free Sample Report
The poc urinalysis market size was valued at US$ 3.44 billion in 2022
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The poc urinalysis market key players are Hoffmann-La Roche Ltd (Switzerland), Dahaner (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ARKRAY, Inc. (Japan), Siemens AG (U.S.), ACON Laboratories Inc. (U.S.), Sysmex Corporation (Japan)
1.Executive Summary |
2.Global POC Urinalysis Market Introduction |
2.1.Global POC Urinalysis Market - Taxonomy |
2.2.Global POC Urinalysis Market - Definitions |
2.2.1. By Test Type |
2.2.2. By Application |
2.2.3. By End User |
2.2.4. By Region |
3.Global POC Urinalysis Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global POC Urinalysis Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global POC Urinalysis Market By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Sediment |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Biochemical |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Flow-Cytometric |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Microscopic |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global POC Urinalysis Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. UTI |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Diabetes |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Liver Disease |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Kidney |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Pregnancy |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global POC Urinalysis Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic Labs |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global POC Urinalysis Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America POC Urinalysis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Sediment |
9.1.2.Biochemical |
9.1.3.Flow-Cytometric |
9.1.4.Microscopic |
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.UTI |
9.2.2.Diabetes |
9.2.3.Liver Disease |
9.2.4.Kidney |
9.2.5.Pregnancy |
9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Diagnostic Labs |
9.3.3.Others |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe POC Urinalysis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Sediment |
10.1.2.Biochemical |
10.1.3.Flow-Cytometric |
10.1.4.Microscopic |
10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.UTI |
10.2.2.Diabetes |
10.2.3.Liver Disease |
10.2.4.Kidney |
10.2.5.Pregnancy |
10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Diagnostic Labs |
10.3.3.Others |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) POC Urinalysis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Sediment |
11.1.2.Biochemical |
11.1.3.Flow-Cytometric |
11.1.4.Microscopic |
11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.UTI |
11.2.2.Diabetes |
11.2.3.Liver Disease |
11.2.4.Kidney |
11.2.5.Pregnancy |
11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Diagnostic Labs |
11.3.3.Others |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) POC Urinalysis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Sediment |
12.1.2.Biochemical |
12.1.3.Flow-Cytometric |
12.1.4.Microscopic |
12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.UTI |
12.2.2.Diabetes |
12.2.3.Liver Disease |
12.2.4.Kidney |
12.2.5.Pregnancy |
12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Diagnostic Labs |
12.3.3.Others |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America POC Urinalysis Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Sediment |
13.1.2.Biochemical |
13.1.3.Flow-Cytometric |
13.1.4.Microscopic |
13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.UTI |
13.2.2.Diabetes |
13.2.3.Liver Disease |
13.2.4.Kidney |
13.2.5.Pregnancy |
13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Diagnostic Labs |
13.3.3.Others |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Hoffmann-La Roche Ltd (Switzerland) |
14.2.2.Dahaner (U.S.) |
14.2.3.Bio-Rad Laboratories, Inc. (U.S.) |
14.2.4.ARKRAY, Inc. (Japan) |
14.2.5.Siemens AG (U.S.) |
14.2.6.ACON Laboratories Inc. (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players